|
000
| 01326nam 2200301zi 4500 |
|---|
| 001 | 9.931575 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240122170000 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 231219e20190823onc o f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-471/2019E-PDF |
|---|
| 245 | 00|aBiosimilar biologic drugs in Canada : |bfact sheet. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada, |cAugust 23, 2019. |
|---|
| 300 | |a1 online resource (10 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Médicaments biologiques biosimilaires au Canada : fiche d’information. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 650 | 0|aPharmaceutical biotechnology|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tMédicaments biologiques biosimilaires au Canada : |w(CaOODSP)9.932795 |
|---|
| 856 | 40|qPDF|s127 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-471-2019-eng.pdf |
|---|
| 856 | 40|qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/fact-sheet-biosimilars.html |
|---|